ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

US Files Motion To Dismiss Fisher Suit Over Database Flags

November 3, 1995

Administration Pledges To Fund Increase For NIH Regardless Of Tobacco Legislation

February 6, 1998